Celonic, a Swiss-based biologics CDMO, and Leukocare, which provides drug product development services, entered into a collaboration to support biopharmaceutical companies developing increasingly ...
New upstream perfusion capabilities strengthen Cytovance’s ability to support next-generation biologics development with great flexibility, productivity, and process optimization Cytovance Biologics, ...
Cell line development continues to improve biologics manufacturing. This article explores how new tools are increasing ...
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known ...
Omnia Biologics, Inc. and Aparna Biosciences Corp. have announced a deal for Omnia to provide AparnaBio with process development and production services. Omnia will provide lentiviral vector technical ...
This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...
With an emphasis on the product development challenges and regulatory expectations in the US, Europe and other highly regulated regions, this workshop provides an in-depth study of the chemistry, ...
ATLANTA and MISSISSAUGA, ON, May 28, 2025 /PRNewswire/ -- Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing ...
Hosted on MSN
Biologics X 3DCC conference 2026: Merging innovation, drug development, and translation for the next era of biopharma
India's first of-its-kind, 6th Annual Summit on Biopharmaceutical Product Development in conjunction with the 3rd edition of the International Conference on Advances in 3D Cell Culture. Date and Venue ...
This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...
OKLAHOMA CITY, July 15, 2026--(BUSINESS WIRE)--Cytovance Biologics, a leading US-based contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results